Jorge Moll – Tech Advancements in Medicine and Institute Studies

Mr. Jorge Neval Moll Neto is the current owner of the D Or Hospital Network, which better known as the Hospital Group. The Brazilian network is the largest one comprising a private group of hospitals in Brazil.

The D Or Hospital Network also includes the D Or institute of Research and Education or IDOR for short. Mr. Jorge Neval Moll Neto, the President of Idor, has been working alongside other experts in order to find if there is a connection between happiness and volunteer work. As it turns out, the relationship between the two is a rather strong and straightforward one. Learn more about Jorge Moll at Google Scholar.

The project was taken on by a group of neuroscientists who worked on the study for almost a year. They conducted several studies and discovered that 28 percent of the Brazilian population performs volunteer work of some kind. Further studies show that the other 72 percent of the people who had never done volunteer work are commonly people who are either too young, have received low schooling, or have very little resources.

The research of relation between happiness and doing volunteer work has shown a clear link between the action the part of the brain that creates a sense of pleasure, satisfaction, and a sense of belonging. Read more about Jorge Moll at crunchbase.com.

There have been other studies over the years that have also shown similar results. One of those studies linked doing volunteer work with business success. People who put in the time and effort to help and take care of others are far more likely to succeed in their business endeavors through honesty and hard work.

The D Or Institute for Research and Education has also been working on projects for tech advancement to us in medicine. Mr. Jorge Moll is deeply invested in the concept of medicine through technology as he believes that doctors can use them to be more efficient while they pat more attention to the patient. The personal interaction between patient and doctor is very important. Software and the advancements have a strong potential for providing better and more accurate health care to patients and to make people focus on health more.

View: https://loop.frontiersin.org/people/6678/overview

Clay Siegall Innovation Come True and Saves People Living with Cancer

Clay Siegall is the CEO of a biotechnological company that was founded in 1998 on the premises of innovative scientific research. Clay Siegall is a trained scientist who has passionately invested his time in discovering new medicines that could cure patients. He is a focused man who has great ambition and great goals, which has driven him to create an extension of the biotechnological company. The extension is Seattle Genetics, which has helped many patients identify their genes, cure and administer the cure to those in need.

Seattle Genetics also focuses on general illnesses and other diseases, but most specifically on cancer. Most of the time, Settle Genetics deals with research therapy to find an effective and efficient one. This is to say Settle Genetics looks into developing a fully utilizable drug therapy that will be in a position to target cancer cells in the patient’s body and kill them. Seattle Genetics is trying to give better services and effective ones compared to chemotherapy.

It said that scientists and doctors who normally assist in research are mostly committed to providing the best services to their patients at all times. The most significant factor that Seattle focuses much is best services to patients and its employees. Clay Siegall has laid very strong rules on how drug therapy should be conducted so as to make sure patients get minimal or no effect on their bodies once they are administered with a therapeutic drug.

Clay Siegall graduated from Washington University with a PhD in Genetics. From the University, Dr. Siegall joined Bristol-Myers Squibb Pharmaceutical Research Cancer Institute. This formed a foundation for Settle Genetics, which is doing great around the world. Dr. Siegall together with his team are highly focused on discovering drugs that have not been met by other medical institution. In short, the CEO and Founder of Seattle Genetics is committed to meeting unexplored genetic areas that will administer cancer treatment and better humankind’s life.

Dr. Siegall is one passionate man that does not surrender in his dream. He has always invested his time, money and energy into bettering the life of humankind. He has formed a basis of other people to learn and achieve greatness. He serves as a role model in terms of motivation, mission and vision. His company has developed many biogenetics technologies that are fast, high quality and advanced. These techniques have helped him manufacture the most world known cancer-treating medicine.